Expression biomarkers for clinical efficacy and outcome prediction in cancer

By Strand Kathryn J   Khalak Hanif   Strovel Jeffrey W   Ebner Reinhard   Augustus Meena  

Pharmacogenomics, Vol. 7, Iss. 1, 2006-01 ,pp. : 105-115

Future Medicine

Access to resources Recommend Favorite

Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome

By  

Current Pharmacogenomics, Vol. 1, Iss. 3, 2003-09 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite

Gallbladder cancer: current status

By Malik Imtiaz A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 6, 2004-06 ,pp. : 1271-1277

Informa Healthcare

Access to resources Recommend Favorite

Rapid deaminator status is associated with poor clinical outcome in pancreatic cancer patients treated with a gemcitabine-based regimen

By Serdjebi Cindy   Seitz Jean-François   Ciccolini Joseph   Duluc Muriel   Norguet Emmanuelle   Fina Frédéric   Lacarelle Bruno   Ouafik L'Houcine   Dahan Laetitia  

Pharmacogenomics, Vol. 14, Iss. 9, 2013-07 ,pp. : 1047-1051

Future Medicine

Access to resources Recommend Favorite

Remacemide: current status and clinical applications

By Schachter S.C.   Tarsy D.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 871-37

Informa Healthcare

Access to resources Recommend Favorite